Tyra Biosciences, Inc. [Rocket]

In millions, except per share items	Dec-31-22	Dec-05-22	Dec-31-21	Dec-05-21	Dec-31-20	Dec-31-19
	10-K	8-K	10-K	8-K	10-K	S-1/A
Revenues	0.0	43.0	0.0	20.6	0.0	1.8
Revenue growth		108.4%			-100.0%
Cost of goods sold	0.0	58.9	0.0	26.3	0.0	3.1
Gross profit	0.0	-15.9	0.0	-5.7	0.0	-1.3
Gross margin		-37.0%		-27.4%		-74.4%
Selling, general and administrative [+]	15.9	15.9	5.7	5.7	2.1	1.3
General and administrative	15.9	15.9	5.7	5.7	2.1	1.3
Research and development	43.0		20.6		7.2
Other operating expenses		27.1		15.0		0.5
EBITDA [+]	-58.6		-26.1		-9.3	-3.1
EBITDA growth	124.2%	124.2%	182.7%		197.0%
EBITDA margin		-137.0%		-127.4%		-174.0%
Depreciation and amortization	0.3		0.1		0.0	0.0
EBIT [+]	-58.9	-58.9	-26.3	-26.3	-9.3	-3.1
EBIT growth	124.2%	124.2%	182.8%		197.8%
EBIT margin		-137.0%		-127.4%		-174.4%
Interest income	3.7	3.7	0.0	0.0	0.0
Interest income	3.7	3.7	0.0	0.0	0.0
Other income (expense), net [+]	0.0	55.3	0.0	26.3	0.0	3.1
Other non-ooperating expenses	-0.1		0.0		0.0
Other	-0.1	-0.1	0.0	0.0	0.0	0.0
Pre-tax income	-55.3	0.0	-26.3	0.0	-9.3	0.0
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0
Net income	-55.3	0.0	-26.3	0.0	-9.3	0.0
Net margin		0.0%		0.0%		0.0%

Basic EPS [+]	($1.32)	$0.00	($1.91)	$0.00	($6.05)	$0.00
Growth	-30.8%		-68.5%
Diluted EPS [+]	($1.32)	$0.00	($1.91)	$0.00	($6.05)	$0.00
Growth	-30.8%		-68.5%

Shares outstanding (basic) [+]	41.9	41,883.9	13.8	13,780.5	1.5	2,650.4
Growth	203.9%	203.9%	793.6%		-99.9%
Shares outstanding (diluted) [+]	41.9	41,883.9	13.8	13,780.5	1.5	2,650.4
Growth	203.9%	203.9%	793.6%		-99.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.